» Articles » PMID: 38106502

Evaluation of DiaSorin Liaison Calprotectin Fecal Assay Adapted for Pleural Effusion

Abstract

Objectives: Calprotectin (CP) is a calcium and zinc binding protein that is widely measured on faecal samples but its determination in other biological fluids might be of interest. The aim of this work was to validate the measurement of CP in pleural fluid by chemiluminescence.

Methods: LIAISONXL, a fully automated chemiluminescence analyzer, was used for CP quantification on pleural fluid. A validation protocol was designed using both quality control materials provided by the manufacturer and pools of pleural fluid samples. Stability, imprecision, bias, linearity, detection capability and carry over effect were evaluated.

Results: CP was stable on pleural fluid at least one week, under refrigerated conditions, and four weeks at -80 °C. The observed intra- and inter-day imprecision was between 2.2 and 6.49 %, with a negative bias under 5.51 %. The linearity of the method was verified up to 2,000 ng/mL. The LoQ for the assay was 48.52 ng/mL. A statistically significant carry-over effect was observed after measuring CP concentrations above the upper limit of linearity, but given the observed magnitude, a clinically relevant impact should not be expected.

Conclusions: DiaSorin Liaison calprotectin assay allows reliable measurement of CP in pleural fluid.

References
1.
Kotsiou O, Papagiannis D, Papadopoulou R, Gourgoulianis K . Calprotectin in Lung Diseases. Int J Mol Sci. 2021; 22(4). PMC: 7915440. DOI: 10.3390/ijms22041706. View

2.
Fernandes S, Santos P, Fatela N, Baldaia C, Marinho R, Proenca H . Ascitic Calprotectin is a Novel and Accurate Marker for Spontaneous Bacterial Peritonitis. J Clin Lab Anal. 2016; 30(6):1139-1145. PMC: 6807186. DOI: 10.1002/jcla.21994. View

3.
Botana-Rial M, Vazquez-Iglesias L, Casado-Rey P, Paez de la Cadena M, Andrade-Olivie M, Abal-Arca J . Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial. Sci Rep. 2020; 10(1):5679. PMC: 7105479. DOI: 10.1038/s41598-020-62388-y. View

4.
Inciarte-Mundo J, Frade-Sosa B, Sanmarti R . From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis. Front Immunol. 2022; 13:1001025. PMC: 9672845. DOI: 10.3389/fimmu.2022.1001025. View

5.
Jarlborg M, Courvoisier D, Lamacchia C, Martinez Prat L, Mahler M, Bentow C . Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis. Arthritis Res Ther. 2020; 22(1):105. PMC: 7201559. DOI: 10.1186/s13075-020-02190-3. View